Turns out I was wrong about J&J in the race for anti-Viagra. The company announced in 2005 that the FDA was not going to approve the drug. When you're a company of J&J's size, throwing $65 million down the toilet will hardly make a splash.
« J&J Has Competition in the Race for the New Anti-Viagra | Main | Today's Press Release That Will Be Most Closely Scrutinized by the DOJ »
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d834519bc269e200d8354a712d53ef
Listed below are links to weblogs that reference Ooops! J&J's Dapoxetine Was Nixed by the FDA in 2005:
This is only a preview. Your comment has not yet been posted.
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Peter Rost, M.D. writes for BrandweekNRX since August 1, 2007. Dr. Rost is a former VP of Pfizer engaged as a pharma expert witness and pharmaceutical marketing consultant by several law firms. He also writes the daily Pharma Law Blog and is the author of Killer Drug and The Whistleblower. Contact Dr. Rost by clicking here.
Comments